Stiefel

Stockley Park West, , Uxbridge, Middlesex, UB11 1BT , UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Summary of Product Characteristics last updated on the eMC: 10/02/2011
SPC Warticon Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   05-Feb-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



7.

GlaxoSmithKline UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS

Trading as Stiefel
Stockley Park West
Uxbridge
Middlesex
UB11 1BT

 

8.

PL 19494/0073

10.

5 February 2011

Updated on 11/01/2011 and displayed until 10/02/2011
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   17-Jan-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



2.            Qualitative and Quantitative Composition

 

Podophyllotoxin 1.5 mg/g (0.15% w/w). 

 

The cream also contains the following excipients:

Methyl parahydroxybenzoate E218

Propyl parahydroxybenzoate E216

Sorbic acid

Stearyl alcohol

Cetyl alcohol

Butylhydroxyanisole (BHA) E320

 

 

 

For a full list of excipients, see section 6.1

 

 

4.4.         Special Warnings and Precautions for Use

 

Avoid contact with eyes.  Should the cream accidentally come into the eye, the eye should be thoroughly rinsed with water.

 

The hands should be thoroughly washed after each application.  Prolonged contact with healthy skin must be avoided since cream contains an active pharmaceutical substance which could be harmful on healthy skin.

 

This cream contains:

·                     methyl and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed).

·                     sorbic acid, stearyl alcohol and cetyl alcohol which may cause local skin reactions, (e.g. contact dermatitis).

·                     butylhydroxyanisole which may cause local skin reactions (e.g.contact dermatitis), or irritation to the eyes and mucous membranes.

 

 

6.2          Not applicable.

 

6.4          This medicinal product does not require any special storage conditions

 

9.            Date of first authorisation: 26th April 1999

 

                Date of last renewal: 17th January 2010

 

10.          17th January 2010

Updated on 07/01/2010 and displayed until 11/01/2011
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   30-Jun-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change in address of MAH from:

Holtspur Lane

Wooburn Green

High Wycombe

Buckinghamshire HP10 0AU

to:

Eurasia Headquarters

Concorde Road

Maidenhead

Berkshire SL6 4BY

Updated on 27/09/2005 and displayed until 07/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/08/2001 and displayed until 27/09/2005
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   podophyllotoxin